Uncategorized

By David Tuller, DrPH The name myalgic encephalomyelitis is inextricably linked with an outbreak of what appeared by all accounts to be a viral illness at London’s Royal Free Hospital in the second half of 1955. More than 200 people, most of them female staff and students, fell ill. Some reported long-term complications. Although no …

Trial By Error: New Study Reports First-Hand Accounts of 1955 Hospital Outbreak Read More »

By David Tuller, DrPH I have been laying low during the recent holiday and coup season. Today I’m watching the impeachment hearings. And I might find it challenging to get back up to full speed until after New Year’s–which for me will be January 20th, or whichever day the White House is finally de-Trumped. For …

Trial By Error: Tack’s Take on 2020 Studies; Professor Edwards’ Statement to NICE Read More »

By David Tuller, DrPH For decades, investigators have argued over the causes of the illness or cluster of illnesses variously called myalgic encephalomyelitis (ME), chronic fatigue syndrome (CFS),  ME/CFS, CFS/ME and other names. In the absence of an adequate explanation for the debilitating symptoms, a flawed approach to intervention based on the perceived need for …

Trial By Error: Psych Issues Do Not Predict ME/CFS, New Chicago Study Shows Read More »

By David Tuller, DrPH I have sent the following letter to Fiona Godlee, editorial director of BMJ and editor-in-chief of The BMJ, on behalf of Professors Brian Hughes and Vincent Racaniello as well as me. We were responding to the recent editorial regarding the new draft of ME/CFS clinical guidelines from the National Institute for …

Trial By Error: A Letter to BMJ From Prof Hughes, Prof Racaniello and Me Read More »

By David Tuller, DrPH The BMJ has published an online “editorial” slamming the new draft of clinical guidelines for ME/CFS from the National Institute for Health and Care Excellence. The position expressed is an interesting one: Non-pharmacological treatments for “complex conditions” cannot be adequately measured by randomized trials, according to the two authors. It is, …

Trial By Error: BMJ Pushes Back Against New NICE Draft Read More »

by Helen Stillwell The results from a phase I clinical trial to test the safety and immunogenicity of a universal flu vaccine candidate reported encouraging results €“ strong titers of broad and functional antibodies persisted for over a year in healthy adults following vaccination.  Influenza viruses contain segmented RNA genomes. The viral envelope contains two types glycoproteins …

Encouraging clinical data for universal flu vaccine candidate Read More »